Jae-Hyun Hong
Chief Executive Officer at SINIL PHARMACEUTICAL CO., LTD.
Net worth: 12 M $ as of 29/04/2024
Profile
Jae-Hyun Hong is currently the President, Chief Executive Officer & Director at SINIL PHARMACEUTICAL Co., Ltd.
She is also an Investment Manager at DSC Investment, Inc. (Venture Capital).
Ms. Hong holds an MBA from Korea University and an undergraduate degree from Dongduk Women's University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/12/2023 | 2,406,364 ( 20.08% ) | 12 M $ | 29/04/2024 |
Jae-Hyun Hong active positions
| Companies | Position | Start |
|---|---|---|
| SINIL PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 31/12/1999 |
DSC Investment, Inc. (Venture Capital)
 DSC Investment, Inc. (Venture Capital) Investment ManagersFinance DSC Investment, Inc. (Venture Capital) (DSC Investment) is the operating venture capital division of DSC Investment, Inc. The firm was founded in 2012 and is headquartered in Seoul, South Korea. | Private Equity Investor | - |
Training of Jae-Hyun Hong
| Korea University | Masters Business Admin |
| Dongduk Women's University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
| SINIL PHARMACEUTICAL Co., Ltd. | |
DSC Investment, Inc. (Venture Capital)
DSC Investment, Inc. (Venture Capital) Investment ManagersFinance DSC Investment, Inc. (Venture Capital) (DSC Investment) is the operating venture capital division of DSC Investment, Inc. The firm was founded in 2012 and is headquartered in Seoul, South Korea. | Finance |
- Stock Market
- Insiders
- Jae-Hyun Hong